Scientific progress is built through collaboration. We're proud to see new #malaria research from our long-standing collaboration with WEHI (Walter and Eliza Hall Institute of Medical Research) published in Science Magazine. This publication contributes to the growing body of research focused on addressing one of the world's deadliest infectious diseases.
About us
At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.
- Website
-
http://www.msd.com
External link for MSD
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Rahway, New Jersey
- Type
- Public Company
Locations
Employees at MSD
Updates
-
Respiratory syncytial virus (#RSV) is a leading cause of infant hospitalization globally. Learn about one U.S. family’s story when their infant, Charlotte, was hospitalized for RSV: https://go.msd.com/~7ne
-
For more than 40 years in HIV, we’ve seen that meaningful progress starts with listening. We’re proud—and humbled—by the relationships we’ve built with advocates and HIV communities around the world. Learn more about why we’re inspired by Real Life: https://go.msd.com/~4rl
-
Join us today at 9 a.m. ET to learn more about our Q2 2026 #earnings: https://go.msd.com/~6q2
-
Our Q2 2026 #earnings results are live: https://go.msd.com/~e4u Swipe below for perspective from Chairman and CEO Rob Davis.
-
Could AI-assisted tools help identify lung cancer? Explore our efforts to help improve early detection of lung cancer: https://go.msd.com/~v3r
-
Our HIV research is grounded in science and shaped by the lived experiences of the HIV community. We're inspired by the real-life stories of people living with HIV. Learn more: https://go.msd.com/~4rl
-
Today we announced our initial post-approval access plans for our investigational HIV prevention option. We are accelerating our access planning to help ensure that, if approved by the regulatory agency, this HIV prevention option can be accessed by those who need it in low- and middle-income countries. Learn more: https://go.msd.com/~3wv
-
Every chapter of MSD for Mothers brings us closer to a world where no woman loses their life while giving birth. Since our global initiative was announced at the UN General Assembly in 2011, what began as a bold commitment has grown into the largest private sector-led maternal health initiative, reaching 40 million women through partnerships, community-driven solutions and data-led impact. Read the full story: https://go.msd.com/~6qt #MSDForMothers